General Information of Drug Off-Target (DOT) (ID: OTKG8IUG)

DOT Name Tetratricopeptide repeat protein 31 (TTC31)
Synonyms TPR repeat protein 31
Gene Name TTC31
UniProt ID
TTC31_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF13432
Sequence
MAPIPKTVGRIKLDCSLRPSCPLEVAAAPKLCKEFGPEDYGEEDIVDFLRRLVESDPQGL
HRIHVDGSSGRLQLWHHDYLLGHLDDEGKSTGQSDRGKGAEGLGTYCGLRKSFLYPPQES
EPCPQSPSASATFPSVSDSLLQVAMPQKLLVTEEEANRLAEELVAEEERMKQKAEKKRLK
KKRQKERKRQERLEQYCGEPKASTTSDGDESPPSSPGNPVQGQCGEEEDSLDLSSTFVSL
ALRKVGDWPLSARREKGLNQEPQGRGLALQKMGQEEESPPREERPQQSPKVQASPGLLAA
ALQQSQELAKLGTSFAQNGFYHEAVVLFTQALKLNPQDHRLFGNRSFCHERLGQPAWALA
DAQVALTLRPGWPRGLFRLGKALMGLQRFREAAAVFQETLRGGSQPDAARELRSCLLHLT
LQGQRGGICAPPLSPGALQPLPHAELAPSGLPSLRCPRSTALRSPGLSPLLHYPSCHRSH
PNQPLSQTQSRRPHPLKPQDPSKGWDILGLGLQHLSQAR

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Tetratricopeptide repeat protein 31 (TTC31). [1]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Tetratricopeptide repeat protein 31 (TTC31). [2]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Tetratricopeptide repeat protein 31 (TTC31). [3]
Selenium DM25CGV Approved Selenium decreases the expression of Tetratricopeptide repeat protein 31 (TTC31). [4]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Tetratricopeptide repeat protein 31 (TTC31). [5]
Tocopherol DMBIJZ6 Phase 2 Tocopherol decreases the expression of Tetratricopeptide repeat protein 31 (TTC31). [4]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of Tetratricopeptide repeat protein 31 (TTC31). [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
2 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
3 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
4 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
5 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
6 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.